Drug intelligence / Profile preview

5-(4-phenoxyphenyl)-5-(4-pyrimidin-2-ylpiperazin-1-yl)pyrimidine-2,4,6(2H,3H)-trione

Development stage
Unknown
Modality
Small Molecules
01

Overview

This compound is a synthetic small molecule with the chemical formula C24H22N6O4 and a molecular weight of approximately 458.47 g/mol[1][3][8]. It belongs to the class of diphenylethers and features both phenoxypenyl and pyrimidinylpiperazine moieties attached to a pyrimidine trione core[1][7]. The compound is listed in drug databases as an experimental molecule but does not have an assigned therapeutic indication or known mechanism of action in clinical use. Its structure has been studied as a ligand in protein-ligand interaction research (notably PDB ligand code "4MR"), suggesting utility primarily as a chemical probe or fragment for structural biology studies rather than as an approved pharmaceutical agent[3][9].

Other names
5-(4-PHENOXYPHENYL)-5-(4-PYRIMIDIN-2-YLPIPERAZIN-1-YL)PYRIMIDINE-2,4,6(2H,3H)-TRIONE5-(4-Phenoxyphenyl)-5-[4-(2-pyrimidinyl)-1-piperazinyl]-2,4,6(1H,3H,5H)-pyrimidinetrione

Beyond the preview

Go deeper on 5-(4-phenoxyphenyl)-5-(4-pyrimidin-2-ylpiperazin-1-yl)pyrimidine-2,4,6(2H,3H)-trione.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 5-(4-phenoxyphenyl)-5-(4-pyrimidin-2-ylpiperazin-1-yl)pyrimidine-2,4,6(2H,3H)-trione.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call